The Future of At-Home Diagnostics
HemaSpot SE
HemaSpot devices set the industry standard for at-home analytics, with the lowest failure rates across all dried blood spot technologies. Designed for both precision and stability, HemaSpot ensures top-tier sample quality, making it the preferred choice for telehealth and remote testing platforms.
The device’s patented clamshell design dries samples in just 30 seconds — far faster than alternatives that require up to 25 minutes of dry time — stabilizing samples for over 30 days.
This design maintains exceptional sample integrity without special shipping, making HemaSpot ideal for large-scale diagnostic use, while reducing risks and improving patient compliance.
Ease of Use
A simple fingerstick provides enough blood for up to twenty diagnostic tests, eliminating the need for clinic visits and streamlining patient care.
Low Error Rate
With only a 5% failure rate, HemaSpot SE significantly reduces the likelihood of retests, enhancing the reliability of patient results and minimizing extra costs.
High Sample Recovery
HemaSpot SE collects up to 500uL of usable sample, enabling over 1/3 more biomarkers to be tested per sample compared to other methods, reducing the need for repeat collections.
Sample Stability
The device preserves the sample for up to 30 days, allowing ambient temperature shipping with no special biohazard packaging required.
Rapid Sample Drying
HemaSpot SE’s integrated desiccant and clamshell design allow for fast drying, making samples ready for shipment within minutes for swift processing & delivery.
Cost-Effective Solution
Designed to lower overall testing expenses, HemaSpot SE’s compatibility with standard mail and reduced need for retests result in considerable cost savings for healthcare providers.